The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense.
Trypanosoma brucei gambiense causes 97% of all cases of African sleeping sickness, a fatal disease of sub-Saharan Africa. Most species of trypanosome, such as T. b. brucei, are unable to infect humans due to the trypanolytic serum protein apolipoprotein-L1 (APOL1) delivered via two trypanosome lytic...
Saved in:
| Main Authors: | Paul Capewell, Caroline Clucas, Eric DeJesus, Rudo Kieft, Stephen Hajduk, Nicola Veitch, Pieter C Steketee, Anneli Cooper, William Weir, Annette MacLeod |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1003686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.
by: Paul Capewell, et al.
Published: (2011-09-01) -
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
by: Andrew P Jackson, et al.
Published: (2010-04-01) -
Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole.
by: Pieter C Steketee, et al.
Published: (2021-11-01) -
Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.
by: Fabrice E Graf, et al.
Published: (2013-01-01) -
Population genetics of Trypanosoma brucei rhodesiense: clonality and diversity within and between foci.
by: Craig W Duffy, et al.
Published: (2013-11-01)